Evidence map›Paper›PMID 41782001›Full record

ArticleMolecular cancer2026

LncRNA NEAT1 promotes immunosuppression in gastric cancer under endoplasmic reticulum stress by maintaining the M

Youqin Xu, Rui Xu, Zixin Chen, Hangyu Zhou, Jiaqi Liao, Kaiyuan Ji, Shengnan Yang, Xuxian Zhong, Yuanyuan Li, Dongxin Xi and 3 more

Abstract read
In one paragraph

Article in Molecular cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Youqin Xu *Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong Province, 511495, China.
Rui Xu *Department of Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, Guangdong Province, 510515, China.
Zixin ChenDepartment of Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, Guangdong Province, 510515, China.
Hangyu ZhouKey Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong Province, 511495, China.
Jiaqi LiaoDepartment of Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, Guangdong Province, 510515, China.
Kaiyuan JiGuangzhou Key Laboratory of Maternal-Fetal Medicine, Institute of Reproductive Health and Perinatology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, 510515, China.
Shengnan YangDepartment of Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, Guangdong Province, 510515, China.
Xuxian ZhongDepartment of Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, Guangdong Province, 510515, China.
Yuanyuan LiKey Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong Province, 511495, China.
Dongxin XiKey Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong Province, 511495, China.
Qianbing ZhangCancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, 510515, China. carl@smu.edu.cn.
Linping ZhaoKey Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong Province, 511495, China. zlp2022@gzhmu.edu.cn.
Qiang ZuoDepartment of Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, Guangdong Province, 510515, China. nfyyzq@126.com.

Funding

Director of Nanfang Hospital Foundation 2022A005Guangzhou Major Medical Disciplines Project 2025-2027National Natural Science Foundation of China 82373239Natural Science Foundation of Guangdong Province 2024A1515012534Special Topics on Basic and Applied Basic Research in Guangzhou SL2024A04J00648the joint funding project of schools (institutes) and enterprises in Guangzhou SL2024A03J00576
6 · The paper itself

Abstract

backgroundDespite PD1 inhibitors offering new gastric cancer therapies, disease burden persists. Cancer-associated fibroblasts were found to be important in gastric cancer regarding tumor promotion and immunosuppression, but its role in gastric cancer under endoplasmic reticulum stress remained unknown.

methodsWe conducted mass spectrometry in cancer-associated fibroblasts and transcriptomic-seq in exosomes from gastric cancer, combined with single-cell RNA sequencing analysis and spatial transcriptome sequencing analysis in gastric cancer to uncover the cellular crosstalk. Endoplasmic reticulum stressed models were established, and the isolation of primary cells and exosomes were used to uncover the communication between gastric cancer cells and cancer-associated fibroblasts. RNA pull-down, RIP-qPCR, flow cytometry detection and ELISA were used to demonstrate the interaction and immunity function in gastric cancer under endoplasmic reticulum stress. Moreover, we developed αvβ3-targeted cationic liposomes delivering siRNA of lncRNA NEAT1 towards tumor cells in gastric cancer in vivo.

resultsWe found m6A protein METTL3, SEMA3A and lncRNA NEAT1, which interacts with METTL3, were highly expressed in cancer-associated fibroblasts under endoplasmic reticulum stress. Endoplasmic reticulum stress stimulation enhanced exosome secretion from gastric cancer cells and significantly elevated the expression of lncRNA NEAT1 in cancer-associated fibroblasts. LncRNA NEAT1 upregulated METTL3 in CAFs, which resulted in the enhanced m6A methylation of SEMA3A mRNA and amplified Treg-mediating immunosuppression. The combination therapy of siNEAT1@Lip-cRGD and anti-PD1 boosted T-cell infiltration and suppressed tumor growth in vivo.

conclusionsOur study unveiled the lncRNA NEAT1/METTL3/SEMA3A axis stimulated by endoplasmic reticulum stress that sustained gastric cancer immunosuppression, providing a rationale for targeting this pathway to improve immunotherapy efficacy.

Indexed as

AdenosineCancer-Associated FibroblastsEndoplasmic Reticulum StressRNA, Long NoncodingSemaphorin-3AStomach NeoplasmsAnimalsCell Line, TumorExosomesGene Expression Regulation, NeoplasticHumansMiceRNA MethylationAdenosineN-methyladenosineRNA, Long NoncodingSemaphorin-3ACAFsEndoplasmic reticulum stressGastric cancerLncRNA NEAT1M6A methylationSEMA3A

Identifiers

PMID41782001
PMCPMC13069744

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.